These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1875043

  • 1. Squamous carcinoma cell lines produce 1,25 dihydroxyvitamin D, but fail to respond to its prodifferentiating effect.
    Bikle DD, Pillai S, Gee E.
    J Invest Dermatol; 1991 Sep; 97(3):435-41. PubMed ID: 1875043
    [Abstract] [Full Text] [Related]

  • 2. Squamous carcinoma cell lines fail to respond to 1,25-Dihydroxyvitamin D despite normal levels of the vitamin D receptor.
    Ratnam AV, Bikle DD, Su MJ, Pillai S.
    J Invest Dermatol; 1996 Mar; 106(3):522-5. PubMed ID: 8648187
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor receptor expression related to differentiation capacity in normal and transformed keratinocytes.
    Boonstra J, De Laat SW, Ponec M.
    Exp Cell Res; 1985 Dec; 161(2):421-33. PubMed ID: 2998836
    [Abstract] [Full Text] [Related]

  • 4. Defective low-density lipoprotein metabolism in cultured, normal, transformed, and malignant keratinocytes.
    Ponec M, Havekes L, Kempenaar J, Lavrijsen S, Vermeer BJ.
    J Invest Dermatol; 1984 Dec; 83(6):436-40. PubMed ID: 6209343
    [Abstract] [Full Text] [Related]

  • 5. Squamous cell carcinomas fail to respond to the prodifferentiating actions of 1,25(OH)2D: why?
    Bikle DD, Xie Z, Ng D, Tu CL, Oda Y.
    Recent Results Cancer Res; 2003 Dec; 164():111-22. PubMed ID: 12899516
    [Abstract] [Full Text] [Related]

  • 6. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
    Matsumoto K, Azuma Y, Kiyoki M, Okumura H, Hashimoto K, Yoshikawa K.
    Biochim Biophys Acta; 1991 May 17; 1092(3):311-8. PubMed ID: 1646640
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor-alpha regulation of 1,25-dihydroxyvitamin D production by human keratinocytes.
    Bikle DD, Pillai S, Gee E, Hincenbergs M.
    Endocrinology; 1991 Jul 17; 129(1):33-8. PubMed ID: 1675987
    [Abstract] [Full Text] [Related]

  • 8. DNA damage-inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti-carcinoma effect of 1,25(OH)2 D3.
    Zhang X, Luo F, Li J, Wan J, Zhang L, Li H, Chen A, Chen J, Cai T, He X, Lisse TS, Zhao H.
    Exp Dermatol; 2019 Jan 17; 28(1):45-52. PubMed ID: 30372793
    [Abstract] [Full Text] [Related]

  • 9. Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1 alpha*.
    Nowak RA, Morrison NE, Goad DL, Gaffney EV, Tashjian AH.
    Endocrinology; 1990 Dec 17; 127(6):3061-9. PubMed ID: 2174344
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D and skin cancer.
    Bikle DD.
    J Nutr; 2004 Dec 17; 134(12 Suppl):3472S-3478S. PubMed ID: 15570056
    [Abstract] [Full Text] [Related]

  • 11. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
    Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF.
    Cancer Epidemiol Biomarkers Prev; 1998 May 17; 7(5):391-5. PubMed ID: 9610788
    [Abstract] [Full Text] [Related]

  • 12. 1,25(OH)2D3-regulated human keratinocyte proliferation and differentiation: basic studies and their clinical application.
    Bikle DD.
    J Nutr; 1995 Jun 17; 125(6 Suppl):1709S-1714S. PubMed ID: 7782932
    [Abstract] [Full Text] [Related]

  • 13. Regulation of lipid synthesis in relation to keratinocyte differentiation capacity.
    Ponec M, Kempenaar J, Boonstra J.
    Biochim Biophys Acta; 1987 Oct 17; 921(3):512-21. PubMed ID: 2444262
    [Abstract] [Full Text] [Related]

  • 14. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 17; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 15. All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes.
    Gibson DF, Bikle DD, Harris J.
    J Cell Physiol; 1998 Jan 17; 174(1):1-8. PubMed ID: 9397150
    [Abstract] [Full Text] [Related]

  • 16. Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D.
    Bikle DD, Gee E, Pillai S.
    J Invest Dermatol; 1993 Nov 17; 101(5):713-8. PubMed ID: 8228333
    [Abstract] [Full Text] [Related]

  • 17. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes.
    Bikle DD, Gee E.
    Endocrinology; 1989 Feb 17; 124(2):649-54. PubMed ID: 2463902
    [Abstract] [Full Text] [Related]

  • 18. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck.
    Hager G, Formanek M, Gedlicka C, Thurnher D, Knerer B, Kornfehl J.
    Acta Otolaryngol; 2001 Jan 17; 121(1):103-9. PubMed ID: 11270487
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D and skin cancer: a problem in gene regulation.
    Bikle DD, Oda Y, Xie Z.
    J Steroid Biochem Mol Biol; 2005 Oct 17; 97(1-2):83-91. PubMed ID: 16039846
    [Abstract] [Full Text] [Related]

  • 20. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.
    Bikle DD, Nemanic MK, Gee E, Elias P.
    J Clin Invest; 1986 Aug 17; 78(2):557-66. PubMed ID: 2426308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.